Skip to content

The effects of living skills training on treatment of the patients with Schizophrenia.

Randomized controlled trial of Social and Independent Living Skills Training on function and quality of life for Schizophrenic Patients

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
IRCT
Registry ID
IRCT2013091414499N3
Enrollment
160
Registered
2013-12-07
Start date
2013-11-16
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Schizophrenia. Schizophrenia, schizotypal and delusional disorders

Interventions

Intervention 1: Intervention for control group (occupational therapy): The control group will receive psychosocial services including group therapy (group discussion), leisure activities, arts and str
Rehabilitation
Intervention for control group (occupational therapy): The control group will receive psychosocial services including group therapy (group discussion), leisure activities, arts and structured activit
The treatment for the intervention group is the independent and social living skills package. These skills include medication and symptom management, leisure management and basic conversational skills

Sponsors

Research and Technology Deputy Office of University of Social Welfare and Rehabilitation Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 55 Years

Inclusion criteria

Inclusion criteria: Inclusion Criteria 1 Informed willingness and consent of the patient for participation in the study. 2 Being Diagnosed with schizophrenia according to Diagnostic and Statistical Manual of Mental Disorders, 4th Edition, Text Revision (DSM-IV-TR) criteria; however, after the active phase of illness. 3 Scoring between 40 and 70 on Global Assessment of Functioning (GAF). 4 Having been hospitalized at least for one time. 5 Ranging between 18 to 55 years old. 6 Living in the vicinity of the therapy center. 7 Being literate. 8 Living with family. Exclusion Criteria 1 Any known current drug dependence or abuse and mental retardation. 2 Seizure disorder requiring medication. 3 Serious psychotic disorders other than schizophrenia. 4 Clinically significant physical or neurological disorder. 5 Risk of harming himself/herself and others.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Severity of Psychopathology. Timepoint: Before intervention, upon completion of intervention, and 6 months after completion of intervention. Method of measurement: Positive and Negative Syndrome Scale (PANSS).;Quality of life. Timepoint: Before intervention, upon completion of intervention, and 6 months after completion of intervention. Method of measurement: WHO-Quality of Life Questionnaire.

Secondary

MeasureTime frame
Global Function. Timepoint: before intervention, upon completion of intervention, and 6 months after completion of intervention. Method of measurement: Global Assessment of Functioning.;Patient Satisfaction. Timepoint: Before intervention, upon completion of intervention, and 6 months after completion of intervention. Method of measurement: Client Satisfaction Questionnaire.;Drug Compliance. Timepoint: Before Intervention, upon completion of intervention, and 6 months after completion of intervention. Method of measurement: Drug Compliance Questionnaire.;Family Burden. Timepoint: Before intervention, upon completion of intervention, and 6 months after completion of intervention. Method of measurement: Experience of Caregiving Inventory.;Family Quality of Life. Timepoint: before intervention,upon completion of intervention, and 6 months after completion of intervention. Method of measurement: WHO-Quality of Life.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAshraf Karbalaee Nouri

University of Social Welfare and Rehabilitation Sciences

nouri@uswr.ac.irashraf1345@yahoo.com+98 21 2218 0037

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026